Dermatology NewsTopical Tapinarof and Roflumilast for Psoriasis: Where Do they Fit In?September 10, 2024PsoriasisPsoriatic Arthritis
Dermatology NewsUstekinumab’s ‘Egregious’ Medicare Part B and D Pricing Differences Led to Federal InterventionAugust 30, 2024Business of MedicinePsoriatic ArthritisPsoriasis
Dermatology NewsTYK2 Inhibitor Effective for Psoriasis in Phase 2 StudyAugust 27, 2024PsoriasisPsoriatic Arthritis
Dermatology NewsPatients With Immune-Mediated Inflammatory Diseases, Type 2 Diabetes Reap GLP-1 Receptor Agonist Benefits, TooAugust 23, 2024Psoriatic ArthritisPsoriasisAutoimmune Diseases
Dermatology NewsDo You Have Patients With JAKne — JAK Inhibitor–Associated Acne? Here’s What to KnowAugust 22, 2024AcnePsoriatic ArthritisPediatricsAtopic DermatitisPsoriasisMedical Dermatology
Dermatology NewsChronic Back Pain in Patients With Psoriasis, Uveitis, or Colitis: How Often Is It Axial Spondyloarthritis?August 15, 2024Psoriasis
Dermatology NewsUS Experience With Infliximab Biosimilars Suggests Need for More Development IncentivesAugust 13, 2024PediatricsPsoriatic ArthritisPsoriasis
Dermatology NewsLight Therapy, Phototherapy, Photobiomodulation: New Ways to Heal With LightAugust 9, 2024Medical DermatologyPsoriasis
Dermatology NewsManagement, Evaluation of Chronic Itch in Older AdultsAugust 7, 2024Medical DermatologyAtopic DermatitisPsoriasis
Dermatology NewsAdvantages of a Pediatric Rheumatology/Dermatology Clinic EvaluatedJuly 30, 2024PediatricsPsoriasisAutoimmune DiseasesPsoriatic Arthritis
Dermatology NewsStudy Finds Differences in Side Effect Profiles With Two Oral Psoriasis TherapiesJuly 26, 2024PsoriasisPsoriatic Arthritis
Dermatology NewsRisk of MACE Comparable Among Biologic Classes for Psoriasis, PsAJuly 26, 2024PsoriasisPsoriatic ArthritisMixed Topics
Dermatology NewsMysteries Persist About Tissue Resident Memory T Cells in PsoriasisJuly 25, 2024PsoriasisPsoriatic Arthritis
Dermatology NewsDebate: Should Dermatologists or Rheumatologists Manage Musculoskeletal Symptoms in Patients With Psoriasis?July 23, 2024PsoriasisAutoimmune DiseasesPsoriatic Arthritis
Dermatology NewsPyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
